The Hematologist is the member newsletter of American Society of Hematology (ASH). It is designed for the broad constituency of ASH, all working toward the ultimate goal of conquering blood diseases. The Hematologist updates readers about important developments in the field of hematology and highlights what ASH is doing for its members.
…
continue reading
New scientific developments are transforming the future of cancer treatment and care. Hosted by world-renowned hematologist and medical oncologist Dr. John Leonard, CancerCast is your window into research breakthroughs, innovative therapies and honest accounts of living with and beyond cancer. Questions or suggestions? Email us at cancercast@med.cornell.edu.
…
continue reading
HemeTalks: Conversations in Hematology Education is the latest podcast channel by the American Society of Hematology (ASH)! Explore educational content crafted by subject-matter experts from ASH, tailored to fulfill your professional education requirements. Whether you are a clinician or researcher, HemeTalks provides innovative education designed for every career stage and subspecialty.
…
continue reading
Blood, Sweat and Smears is a podcast focused on thrombosis and hemostasis and is hosted by Benign Hematologist, Dr. Brad Lewis. Dr. Lewis shares some of his knowledge built over decades of experience in hematology and laboratory testing.
…
continue reading
The official podcast feed of MDedge Hematology-Oncology, part of the Medscape Professional Network. On Thursdays, Dr. David Henry interviews key opinion leaders and rising stars in hematology and oncology. The information in this podcast is provided for informational and educational purposes only.
…
continue reading
Unlock the latest breakthroughs in thrombosis diagnosis and management with CLOT Conversations - the must-listen podcast for healthcare professionals. Join hosts Dr Jameel Abdulrehman, a Hematologist with specialization in Thrombosis and Hemostasis at the University Health Network in Toronto, and David Airdrie, the Executive Director of Thrombosis Canada, as they delve into new research and explore the evolving field of thrombosis in 15 to 30 minute easily digestible episodes. Learn from the ...
…
continue reading
The American Society of Hematology Trainee Council is proud to announce the creation of a new podcast to accompany our new trainee-focused publication Hematopoiesis. The podcast is by and for hematology trainees at all levels of training, from medical students to residents to fellows to doctoral students, and all episodes are created and produced by the ASH Trainee Council. With Hematopoiesis and our new podcast, we aim to bring content about the history of hematology, career pathways in hem ...
…
continue reading
In OncLive® On Air, you can expect to hear interviews with academic oncologists on the thought-provoking oncology presentations they give at the OncLive® State of the Science Summits. The topics in oncology vary, from systemic therapies, surgery, radiation therapy, to emerging therapeutic approaches in a particular type of cancer. This includes lung cancer, breast cancer, gastrointestinal cancers, hematologic malignancies, gynecologic cancers, genitourinary cancers, and more.
…
continue reading
CatharSIS is a podcast about the meaning of life, created by Michal and Maayan as a way to honor the life of their dad, an Oncologist/Hematologist who would often ask his patients, family, friends, even strangers: “What’s the meaning of life?” It’s a relatable podcast where two sisters, both Associate Marriage and Family Therapists, interview different people about the meaning of life, existentialism, friendship, relationships, love, death, grief, and nostalgia. If you want to learn more abo ...
…
continue reading
7-2-1 is the podcast of the Foundation for Women & Girls with Blood Disorders (FWGBD). Dr. Sweta Gupta has a passion for taking care of young women with bleeding disorders and heavy menstrual bleeding. 7-2-1 tackles some of the most pressing questions about periods and heavy menstrual bleeding faced by both healthcare providers and their patients: What is normal vs. heavy menstrual bleeding? Demystifying IUDS (LARCS). When should I see a specialist about my periods? Join Dr. Gupta as she eng ...
…
continue reading
I’m Dr. Tammie Chang, creator and host of the LeadHER Podcast for Women Physicians! I’m a pediatric hematologist/oncologist, a leadership coach for women physicians, #1 bestselling author, keynote speaker and the Co-Founder of Pink Coat, MD, a platform dedicated to helping women physicians thrive in their lives and careers. If you’re a woman physician feeling stuck, frustrated, or disempowered, and know deep inside that you want to step into your power as a visionary leader, this podcast is ...
…
continue reading
On air at 95.7FM KQWC for well over a decade, and continues on air and now online!
…
continue reading
I am here to motivate people through the power of love and light and share knowledge I have picked up on my journey. Support this podcast: https://podcasters.spotify.com/pod/show/breadcrumbz/support
…
continue reading
Zavitz Insurance has been providing cutting-edge insurance solutions to our clients for over 32 years.
…
continue reading
JCO Oncology Practice (JCO OP) provides oncologists and other oncology professionals with information and tools to enhance practice efficiency and promote a high standard for quality of patient care. The goal of JCO OP is to be the authoritative resource on clinical and administrative management for practicing oncologists. The Journal includes original research, feature articles, and section columns on various issues pertinent to daily practice operations, all of which are subject to peer re ...
…
continue reading
Waiting is the Hardest podcast is back with all new episodes! The goal of this podcast is to provide hope and healing to others by sharing stories of perseverance and triumph during difficult situations. Season 1 focused on one woman's story of survival following a near fatal car accident. Season 2 will focus on two young ladies healing of sickle cell disease following a bone marrow transplant. Share your story of waiting with us on social media or email us at waitingisthehardestpodcast@gmai ...
…
continue reading
1
S11 Ep23: Navigating Myelofibrosis: Updates for Community Hematologist Oncologists
25:38
25:38
Spela senare
Spela senare
Listor
Gilla
Gillad
25:38
In today’s episode, supported by Sobi, we had the pleasure of speaking with Aaron T. Gerds, MD, MS, and James K. McCloskey, MD, about myelofibrosis treatment advances. Dr Gerds is an assistant professor in the Department of Medicine in the School of Medicine, as well as a member of the Developmental Therapeutics Program at the Case Comprehensive Ca…
…
continue reading
1
Enhancing Risk Stratification for Pediatric B-Cell Acute Lymphoblastic Leukemia: No Longer a ‘PI’ in the Sky Idea?
18:11
18:11
Spela senare
Spela senare
Listor
Gilla
Gillad
18:11
In this episode, Contributing Editor Lauren Pommert, MD, a pediatric oncologist specializing in children with leukemia at Cincinnati’s Children in Cincinnati, Ohio, talks with Natalie DelRocco, PhD, a senior statistician for the Children’s Oncology Group’s Bone Tumors Committee and an assistant professor of clinical population and public health sci…
…
continue reading
1
S11 Ep28: Liquid Biopsy Ushers in a New Era of NSCLC Biomarker Testing: With David R. Gandara, MD
11:29
11:29
Spela senare
Spela senare
Listor
Gilla
Gillad
11:29
In today’s episode, we had the pleasure of speaking with David R. Gandara, MD, about biomarker testing in lung cancer. Dr Gandara is the chief medical officer of the International Society of Liquid Biopsy, the co-director of the Center for Experimental Therapeutics in Cancer, and the senior advisor to the director at the University of California Da…
…
continue reading
1
S11 Ep27: Delve into Recent NCCN Guideline Updates for Hepatobiliary and CRC Management: With Alan P. Venook, MD
11:33
11:33
Spela senare
Spela senare
Listor
Gilla
Gillad
11:33
In today’s episode, we had the pleasure of speaking with Alan P. Venook, MD, about recent updates to the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines for gastrointestinal (GI) cancers. Dr Venook holds the Madden Family Distinguished Professorship in Medical Oncology and Translational Research and is a professor in the D…
…
continue reading
1
Blood Transfusion Safety: TRALI vs TACO
20:03
20:03
Spela senare
Spela senare
Listor
Gilla
Gillad
20:03
Join us as we explore blood transfusion safety, focusing specifically on Transfusion-Related Acute Lung Injury (TRALI) and Transfusion-Associated Circulatory Overload (TACO). Tailored for general hematologists with a foundational understanding of transfusion medicine, this session delves into the pathophysiology, clinical presentation, diagnostic c…
…
continue reading
Immunotherapy is a type of cancer treatment that helps your immune system fight cancer. In the last 10 years, immunotherapy has joined the list of standard cancer treatment approaches, alongside chemotherapy, targeted therapy, radiation therapy, and surgery. There are a number of different types of immunotherapies that work in different ways to tar…
…
continue reading
1
S11 Ep26: Phase 1 Trials Provide Oncology Fellows With Valuable Clinical Research Experience: With Samuel A. Kareff, MD, MPH
14:08
14:08
Spela senare
Spela senare
Listor
Gilla
Gillad
14:08
In today’s episode, we had the pleasure of speaking with Samuel A. Kareff, MD, MPH, about the intersections between early-phase clinical research and meaningful mentorship experiences during oncology/hematology fellowship. Dr Kareff is a medical oncologist and hematologist at the Eugene M. and Christine E. Lynn Cancer Institute, part of Baptist Hea…
…
continue reading
1
S11 Ep25: FDA Approval Insights: Denileukin Diftitox in Relapsed/Refractory CTCL
8:17
8:17
Spela senare
Spela senare
Listor
Gilla
Gillad
8:17
In today’s episode, supported by Citius Pharmaceuticals, we had the pleasure of speaking with Francine Foss, MD, to discuss the FDA approval of denileukin diftitox-cxdl (Lymphir) for the treatment of patients with relapsed/refractory cutaneous T-cell lymphoma (CTCL) who have received 1 or more prior systemic therapies. Dr Foss is a professor of med…
…
continue reading
1
S11 Ep24: How to Apply Research Developments in ALK-Positive NSCLC: With Chandler Park, MD, and Tejas Patil, MD
17:21
17:21
Spela senare
Spela senare
Listor
Gilla
Gillad
17:21
Dr Patil emphasized the significance of the phase 3 CROWN trial (NCT03052608), which compared lorlatinib (Lorbrena) with crizotinib (Xalkori) in patients with ALK-positive metastatic NSCLC. With a hazard ratio of 0.19 (95% CI, 0.13-0.27) for progression-free survival, the trial demonstrated lorlatinib’s superior intracranial control and long-term e…
…
continue reading
1
S11 Ep22: FDA Approval Insights: Vorasidenib in IDH1/2+ Grade 2 Astrocytoma and Oligodendroglioma
12:28
12:28
Spela senare
Spela senare
Listor
Gilla
Gillad
12:28
In today’s episode, supported by Servier Pharmaceuticals, we had the pleasure of speaking with Jennie W. Taylor, MD, MPH, about the FDA approval of vorasidenib (Voranigo) for patients with IDH-positive grade 2 astrocytoma or oligodendroglioma. Dr Taylor is an associate professor of clinical neurology at the University of California, San Francisco (…
…
continue reading
1
S11 Ep21: Updated VISION Trial Data Showcase the Efficacy of Tepotinib in MET + NSCLC: With Martin Dietrich, MD
11:59
11:59
Spela senare
Spela senare
Listor
Gilla
Gillad
11:59
In our exclusive interview, Dr Dietrich discussed key efficacy findings from the 18-month follow-up of the phase 2 VISION trial (NCT02864992), which evaluated the efficacy of tepotinib (Tepmetko) in patients with non–small cell lung cancer harboring MET exon 14 skipping mutations. Additionally, Dr Dietrich emphasized important safety considerations…
…
continue reading
5 Questions is a new series of Blood, Sweat and Smears, hosted by our Senior Director, Bjorn Stromsness, who asks 5 questions to physicians in and around the disease areas we work in. In this episode, we are joined by Dr. Xiao Peng, who recently joined the Children’s Hospital at Montefiore faculty as Assistant Professor in the Division of Genetics,…
…
continue reading
1
S11 Ep20: FDA Approval Insights: Perioperative Durvalumab for Resectable NSCLC
15:09
15:09
Spela senare
Spela senare
Listor
Gilla
Gillad
15:09
In today’s episode, supported by AstraZeneca, we had the pleasure of speaking with Sandip P. Patel, MD, and Brendon M. Stiles, MD, about the FDA approval of perioperative durvalumab (Imfinzi) for patients with resectable non–small cell lung cancer (NSCLC). Dr Patel is a professor of medicine in the Department of Medicine at the University of Califo…
…
continue reading
1
S11 Ep19: Immunotherapy Advances Expand the SCLC Treatment Paradigm: With Chandler Park, MD, and Tejas Patil, MD
15:18
15:18
Spela senare
Spela senare
Listor
Gilla
Gillad
15:18
In part 2 of this 3-part Oncology Unplugged series, Chandler Park, MD, a genitourinary medical oncologist at Norton Cancer Institute in Louisville, Kentucky, and Tejas Patil, MD, an assistant professor of medical oncology at the University of Colorado School of Medicine in Aurora, discussed the evolving small cell lung cancer (SCLC) treatment parad…
…
continue reading
1
S11 Ep18: Board Review Resources 2024
15:25
15:25
Spela senare
Spela senare
Listor
Gilla
Gillad
15:25
Two Onc Docs, hosted by Samantha A. Armstrong, MD, and Karine Tawagi, MD, is a podcast dedicated to providing current and future oncologists and hematologists with the knowledge they need to ace their boards and deliver quality patient care. Dr Armstrong is a hematologist/oncologist and assistant professor of clinical medicine at Indiana University…
…
continue reading
1
S11 Ep17: How Luspatercept Could Shake Up MDS Management—With Rory Shallis, MD
13:01
13:01
Spela senare
Spela senare
Listor
Gilla
Gillad
13:01
In today’s episode, we had the pleasure of speaking with Rory Shallis, MD, an assistant professor of medicine and hematology at Yale School of Medicine, part of Yale New Haven Health in Connecticut. Shallis sat down with us to share some of the research that has been generated in myelodysplastic syndrome (MDS) over the past year or so, touching on …
…
continue reading
1
S11 Ep16: FDA Approval Insights: Afami-Cel for Pretreated, Unresectable or Metastatic Synovial Sarcoma
13:08
13:08
Spela senare
Spela senare
Listor
Gilla
Gillad
13:08
Dr Warner discusses the FDA approval of afami-cel for patients with advanced synovial sarcoma and key findings from the pivotal SPEARHEAD-1 trial.Av OncLive® On Air
…
continue reading
1
S11 Ep15: Thomas and Lukas Highlight Updates in Brain Cancer from the 2024 ASCO Annual Meeting
15:28
15:28
Spela senare
Spela senare
Listor
Gilla
Gillad
15:28
Welcome to OncLive On Air®! I’m your host today, Ashling Wahner. OncLive On Air is a podcast from OncLive®, which provides oncology professionals with the resources and information they need to provide the best patient care. In both digital and print formats, OncLive covers every angle of oncology practice, from new technology to treatment advances…
…
continue reading
1
S11 Ep14: Park and Patil Explore Advances in EGFR + NSCLC From ASCO 2024
19:42
19:42
Spela senare
Spela senare
Listor
Gilla
Gillad
19:42
In Oncology Unplugged, a podcast series from MedNews Week, host Chandler Park, MD, a genitourinary medical oncologist at the Norton Cancer Institute in Louisville, Kentucky, sits down with Tejas Patil, MD, an assistant professor of medicine-medical oncology at the University of Colorado School of Medicine - Anschutz Medical Campus in Aurora. In thi…
…
continue reading
1
S11 Ep13: FDA Approval Insights: Epcoritamab in Relapsed/Refractory Follicular Lymphoma
9:02
9:02
Spela senare
Spela senare
Listor
Gilla
Gillad
9:02
Welcome to OncLive On Air®! I’m your host today, Ashling Wahner. OncLive On Air is a podcast from OncLive®, which provides oncology professionals with the resources and information they need to provide the best patient care. In both digital and print formats, OncLive covers every angle of oncology practice, from new technology to treatment advances…
…
continue reading
1
A Leap of Faith? Elimination of Autologous Stem Cell Transplantation for Patients With Mantle Cell Lymphoma in First Remission
21:39
21:39
Spela senare
Spela senare
Listor
Gilla
Gillad
21:39
In this episode, Contributing Editor Tycel Phillips, MD, an associate professor of medicine and a hematologist-oncologist at City of Hope Medical Center in Duarte, California, talks with Martin Dreyling, MD, a professor of medicine and head of the lymphoma program at LMU Hospital in Munich. They discuss the TRIANGLE trial, conducted by Dr. Dreyling…
…
continue reading
1
Advancing Sickle Cell Disease Care: Navigating Gene Therapy
17:11
17:11
Spela senare
Spela senare
Listor
Gilla
Gillad
17:11
Are you a hematologist or a generalist provider seeking clarity on how to best counsel patients with sickle cell disease (SCD) who are interested in gene therapy? Join us for a podcast session focused on important patient considerations for gene therapy, tailored for SCD providers and clinicians. This session aims to provide practical insights to f…
…
continue reading
1
S11 Ep12: Oncology Experts Preview Top Abstracts From the 2024 ESMO Congress
11:49
11:49
Spela senare
Spela senare
Listor
Gilla
Gillad
11:49
In today’s episode, we invited experts from across oncology specialties to discuss the abstracts and presentations they are most looking forward to seeing at the 2024 ESMO Congress. Emre Yekedüz, MD, an associate professor of medical oncology at Ankara University in Turkey and a research fellow at Dana-Farber Cancer Institute in Boston, Massachuset…
…
continue reading
1
S11 Ep11: Heme & Onc Fellow Board Review Tips 2024
16:03
16:03
Spela senare
Spela senare
Listor
Gilla
Gillad
16:03
Two Onc Docs, hosted by Samantha A. Armstrong, MD, and Karine Tawagi, MD, is a podcast dedicated to providing current and future oncologists and hematologists with the knowledge they need to ace their boards and deliver quality patient care. Dr Armstrong is a hematologist/oncologist and assistant professor of clinical medicine at Indiana University…
…
continue reading
1
S11 Ep10: Florez Focuses on Patient-Centered NSCLC Biomarker Testing Discussions
11:53
11:53
Spela senare
Spela senare
Listor
Gilla
Gillad
11:53
In today’s episode, we had the pleasure of speaking with Narjust Florez, MD, about patient-focused lung cancer biomarker testing discussions.Av OncLive® On Air
…
continue reading
1
5 Questions with Dr. Anita Dhanrajani
11:54
11:54
Spela senare
Spela senare
Listor
Gilla
Gillad
11:54
5 Questions is a new series of Blood, Sweat and Smears, hosted by our Senior Director, Bjorn Stromsness, who asks 5 questions to physicians in and around the disease areas we work in. In this episode, we are joined by Dr. Anita Dhanrajani, a pediatric rheumatologist at Children's Hospital New Orleans, specializing in children with autoimmune diseas…
…
continue reading
1
S11 Ep9: Park and Graff Explore the Evolving Role of CDK4/6 Inhibitors in Metastatic Breast Cancer
21:47
21:47
Spela senare
Spela senare
Listor
Gilla
Gillad
21:47
Drs Park and Graff discuss the evolution of treatment for patients with metastatic HR-positive breast cancer, including the role of CDK4/6 inhibitors.Av OncLive® On Air
…
continue reading
1
S11 Ep8: Salgia Summarizes the Benefits of Tepotinib in MET Exon 14–Mutated NSCLC
12:55
12:55
Spela senare
Spela senare
Listor
Gilla
Gillad
12:55
Dr Salgia discusses how he chooses between tepotinib and capmatinib in patients with stage IV NSCLC harboring MET exon 14 skipping mutations.Av OncLive® On Air
…
continue reading
1
S11 Ep7: Chiang Contextualizes the Optimal Use of Lurbinectedin in SCLC Management
8:41
8:41
Spela senare
Spela senare
Listor
Gilla
Gillad
8:41
Dr Chiang discusses the use of lurbinectedin in small cell lung cancer and tips for managing toxicities associated with this agent.Av OncLive® On Air
…
continue reading
In this episode, Contributing Editor Surbhi Shah, MD, a classical hematologist at Mayo Clinic in Phoenix, leads a conversation about anticoagulation stewardship. Her guests are Allison Burnett, PharmD, PhC, an antithrombosis stewardship pharmacist at the University of New Mexico Hospital and president of the Anticoagulation Forum, and Geoffrey Barn…
…
continue reading
1
S11 Ep6: FDA Approval Insights: Dostarlimab Plus Chemotherapy in Advanced/Recurrent Endometrial Cancer
8:37
8:37
Spela senare
Spela senare
Listor
Gilla
Gillad
8:37
Dr Tewari discusses the FDA approval of dostarlimab plus chemotherapy for patients with primary advanced or recurrent endometrial cancer.Av OncLive® On Air
…
continue reading
1
S11 Ep5: Jhaveri on the INAVO120 Trial of Inavolisib/Palbociclib/Fulvestrant in PIK3CA -Mutant, HR+ Breast Cancer
9:17
9:17
Spela senare
Spela senare
Listor
Gilla
Gillad
9:17
Dr Jhaveri discusses the INAVO120 trial of inavolisib plus palbociclib and fulvestrant in PIK3CA-mutant, HR-positive metastatic breast cancer.Av OncLive® On Air
…
continue reading
1
Updates in Thalassemia: New Challenges and Novel Treatment Approaches
20:19
20:19
Spela senare
Spela senare
Listor
Gilla
Gillad
20:19
Speakers: Alexis Thompson, MD, and Sujit Sheth, MD Description: For general hematologists with a foundational understanding of thalassemia, this episode discusses the changing demographics due to immigration and refugee resettlement. It covers the diagnosis process from newborn screening to older individuals, emphasizing genetic testing due to nume…
…
continue reading
1
S11 Ep4: Park and Kasi Expand on Perioperative Immunotherapy Updates in CRC
10:46
10:46
Spela senare
Spela senare
Listor
Gilla
Gillad
10:46
Drs Park and Kasi delve into the shift toward neoadjuvant immunotherapy and the use of ctDNA as a prognostic tool in colorectal cancer.Av OncLive® On Air
…
continue reading
1
S11 Ep3: Garcia-Manero on MDS Treatment Updates With Luspatercept and Beyond
15:00
15:00
Spela senare
Spela senare
Listor
Gilla
Gillad
15:00
Dr Garcia-Manero discusses findings from research in myelodysplastic syndromes that were presented at the 2024 EHA Congress.Av OncLive® On Air
…
continue reading
1
Navigating Ovarian Cancer: VDMC Provider Jade Williams, ARNP, AGRCNP-BC shares her story. Episode 3
28:57
28:57
Spela senare
Spela senare
Listor
Gilla
Gillad
28:57
Tune in to hear from VDMC Provider Jade Williams as she shares her journey on the other side of the room, as a patient navigating ovarian cancer.Av Van Diest Medical Center
…
continue reading
1
S11 Ep3: FDA Approval Insights: Durvalumab/Chemotherapy in dMMR Advanced Endometrial Cancer
9:25
9:25
Spela senare
Spela senare
Listor
Gilla
Gillad
9:25
Dr Westin discusses the FDA approval of durvalumab plus chemotherapy for patients with dMMR advanced or recurrent endometrial cancer.Av OncLive® On Air
…
continue reading
1
S11 Ep2: ASCO 2024 Plenary: NADINA Trial Neoadjuvant Ipi/Nivo vs Adjuvant Nivo for Resectable Stage III Melanoma
10:09
10:09
Spela senare
Spela senare
Listor
Gilla
Gillad
10:09
Drs Armstrong and Tawagi discuss the NADINA trial of neoadjuvant nivolumab/ipilimumab vs adjuvant nivolumab in resectable, macroscopic, stage III melanoma.Av OncLive® On Air
…
continue reading
1
S11 Ep1: Rotow Reviews Key Updates on the Management of CNS Metastases in NSCLC
10:13
10:13
Spela senare
Spela senare
Listor
Gilla
Gillad
10:13
Dr Rotow discusses data that demonstrated the central nervous system activity of datopotamab deruxtecan and osimertinib in patients with NSCLC.Av OncLive® On Air
…
continue reading
1
S10 Ep50: Park and Grivas Expand on Treatment Updates in Bladder Cancer
16:13
16:13
Spela senare
Spela senare
Listor
Gilla
Gillad
16:13
Drs Park and Grivas discuss bladder cancer treatment updates, including results from the SunRISe-1 trial of TAR-200 plus cetrelimab in NMIBC.Av OncLive® On Air
…
continue reading
1
Reproductive Health and Sickle Cell Disease (Part II)
20:05
20:05
Spela senare
Spela senare
Listor
Gilla
Gillad
20:05
In our 8th episode, we continue the conversation from Episode 7: Reproductive Health and Sickle Cell Disease. Joining our hosts, Dr. Sweta Gupta and Dr. Tricia Huguelet, are two guests – Dr. Zachary Ramsay and Dr. Christy Bemrich-Stolz, who share their experience both as researchers and clinicians in treating sickle cell disease. Dr. Ramsay is a ph…
…
continue reading
1
Meet Dr. Daulath Singh - Medical Oncologist and Hematologist
23:24
23:24
Spela senare
Spela senare
Listor
Gilla
Gillad
23:24
Tune in and get to know our newest visiting specialist at VDMC Specialty Clinic, Medical Oncologist and Hematologist Dr. Daulath Singh.Av Van Diest Medical Center
…
continue reading
1
S10 Ep49: Halmos on the AE Profiles of Dato-DXd and Other ADCs in NSCLC
10:02
10:02
Spela senare
Spela senare
Listor
Gilla
Gillad
10:02
Dr Halmos discusses common AEs associated with the ADCs that are used in NSCLC and ways to manage and mitigate these toxicities.Av OncLive® On Air
…
continue reading
5 Questions is a new series of Blood, Sweat and Smears, hosted by our Senior Director, Bjorn Stromsness who asks 5 questions to physicians in and around the disease areas we work in. In this episode, we are joined by Dr. Ashley Gefen, MD, a pediatric nephrologist specializing in genetic kidney diseases, tubular disorders, and kidney stone disease a…
…
continue reading
1
ANNEXA-4 G.I. Sub-analysis - Dr Deborah Siegal
23:56
23:56
Spela senare
Spela senare
Listor
Gilla
Gillad
23:56
Dr Deborah Siegal joins us for a discussion on the recent paper, The Efficacy and Safety of Andexanet Alfa in Patients With Acute Gastrointestinal Bleeding While Taking Factor Xa Inhibitors: An ANNEXA-4 Sub-analysis. In this wide-ranging discussion she reviews the results of the sub-analysis and the need for anticoagulant reversal for acute GI blee…
…
continue reading
1
S10 Ep48: Lisberg Lends Insight About the TROPION-Lung01 Trial of Dato-DXd in NSCLC
12:49
12:49
Spela senare
Spela senare
Listor
Gilla
Gillad
12:49
Dr Lisberg discusses key findings from the TROPION-Lung01 trial of Dato-DXd in patients with previously treated advanced or metastatic NSCLC.Av OncLive® On Air
…
continue reading
1
Reproductive Health and Sickle Cell Disease (Part I)
26:12
26:12
Spela senare
Spela senare
Listor
Gilla
Gillad
26:12
Although we have made leaps and strides in the treatment of sickle cell disease with the development of several disease-modifying medications and gene therapies, as physicians we still grapple with basic health issues, specifically for young girls and women, including – menstrual pain, fertility, maintaining a healthy pregnancy, and positive outcom…
…
continue reading
The American Society of Clinical Oncology, or ASCO, Annual Meeting is the largest global oncology conference and features state-of-the-art research presentations and cancer care insights from oncology professionals around the world. Every year on the CancerCast podcast, two of Weill Cornell Medicine’s leading experts discuss exciting research stemm…
…
continue reading
1
S10 Ep47: Pegram Details the Use of Oral SERDs in ESR1+ Metastatic Breast Cancer
11:09
11:09
Spela senare
Spela senare
Listor
Gilla
Gillad
11:09
Av OncLive® On Air
…
continue reading
1
S10 Ep47: Miller Discusses the Use of Selinexor in TP53 Wild-Type Advanced Endometrial Cancer
11:09
11:09
Spela senare
Spela senare
Listor
Gilla
Gillad
11:09
Dr Miller discusses findings from the SIENDO trial of selinexor maintenance therapy in patients with TP53 wild-type advanced endometrial cancer.Av OncLive® On Air
…
continue reading